Relationship between Functional Profile of HIV-1 Specific CD8 T Cells and Epitope Variability with the Selection of Escape Mutants in Acute HIV-1 Infection
暂无分享,去创建一个
Mario Roederer | Bette Korber | Guido Ferrari | Persephone Borrow | Natalie Hawkins | Clive M. Gray | Andrew J. McMichael | Barton F. Haynes | Georgia D. Tomaras | B. Korber | B. Haynes | S. Self | I. Williams | C. Gray | A. McMichael | M. Betts | P. Borrow | M. Roederer | G. Ferrari | J. Salazar-Gonzalez | G. Tomaras | E. Turnbull | K. Weinhold | N. Goonetilleke | P. Pellegrino | Michael K P Liu | Nilu Goonetilleke | Jesus F. Salazar-Gonzalez | Pierre Pellegrino | Ian Williams | Emma L. Turnbull | Steve Self | Michael K. P. Liu | Michael R. Betts | Kent J. Weinhold | C. Gay | Cynthia Gay | Sydeaka Watson | Kara McGhee | Natalie R. Hawkins | S. Watson | Kara McGhee | G. Ferrari
[1] C. Ward‐Caviness,et al. Secretion of MIP-1β and MIP-1α by CD8(+) T-lymphocytes correlates with HIV-1 inhibition independent of coreceptor usage. , 2011, Cellular immunology.
[2] G. Tomaras,et al. Epigenetic regulation of CD8(+) T-lymphocyte mediated suppression of HIV-1 replication. , 2010, Virology.
[3] Alan S. Perelson,et al. Transmission of Single HIV-1 Genomes and Dynamics of Early Immune Escape Revealed by Ultra-Deep Sequencing , 2010, PloS one.
[4] J. Kappes,et al. Phenotypic and Functional Profile of HIV-Inhibitory CD8 T Cells Elicited by Natural Infection and Heterologous Prime/Boost Vaccination , 2010, Journal of Virology.
[5] Alan S. Perelson,et al. CD8+ Lymphocytes Control Viral Replication in SIVmac239-Infected Rhesus Macaques without Decreasing the Lifespan of Productively Infected Cells , 2010, PLoS pathogens.
[6] S. Pillai,et al. In Vivo CD8+ T-Cell Suppression of SIV Viremia Is Not Mediated by CTL Clearance of Productively Infected Cells , 2010, PLoS pathogens.
[7] D. van Baarle,et al. HLA-B molecules target more conserved regions of the HIV-1 proteome , 2010, AIDS.
[8] Persephone Borrow,et al. The immune response during acute HIV-1 infection: clues for vaccine development , 2009, Nature Reviews Immunology.
[9] Jerome H. Kim,et al. Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand. , 2009, The New England journal of medicine.
[10] B. Autran,et al. Antigen sensitivity is a major determinant of CD8+ T-cell polyfunctionality and HIV-suppressive activity. , 2009, Blood.
[11] Alan S. Perelson,et al. The first T cell response to transmitted/founder virus contributes to the control of acute viremia in HIV-1 infection , 2009, The Journal of experimental medicine.
[12] A. Perelson,et al. Genetic identity, biological phenotype, and evolutionary pathways of transmitted/founder viruses in acute and early HIV-1 infection , 2009, The Journal of experimental medicine.
[13] Xiping Wei,et al. Kinetics of Expansion of Epitope-Specific T Cell Responses during Primary HIV-1 Infection1 , 2009, The Journal of Immunology.
[14] R. Koup,et al. Association of HIV-Specific and Total CD8+ T Memory Phenotypes in Subtype C HIV-1 Infection with Viral Set Point1 , 2009, The Journal of Immunology.
[15] Pratip K. Chattopadhyay,et al. Public clonotype usage identifies protective Gag-specific CD8+ T cell responses in SIV infection , 2009, The Journal of experimental medicine.
[16] S. Sieg,et al. Faculty Opinions recommendation of Effector memory T cell responses are associated with protection of rhesus monkeys from mucosal simian immunodeficiency virus challenge. , 2009 .
[17] J. Kublin,et al. Post-step modifications for research on HIV vaccines. , 2009, AIDS.
[18] D. Montefiori,et al. Immune Control of an SIV Challenge by a T Cell-Based Vaccine in Rhesus Monkeys , 2008, Nature.
[19] M. Essex,et al. Reduced Viral Replication Capacity of Human Immunodeficiency Virus Type 1 Subtype C Caused by Cytotoxic-T-Lymphocyte Escape Mutations in HLA-B57 Epitopes of Capsid Protein , 2008, Journal of Virology.
[20] Donald K Carter,et al. HIV-1 vaccine-induced immunity in the test-of-concept Step Study: a case–cohort analysis , 2008, The Lancet.
[21] V. Appay,et al. Phenotype and function of human T lymphocyte subsets: Consensus and issues , 2008, Cytometry. Part A : the journal of the International Society for Analytical Cytology.
[22] D. H. Young,et al. Magnitude and Complexity of Rectal Mucosa HIV-1-Specific CD8+ T-Cell Responses during Chronic Infection Reflect Clinical Status , 2008, PloS one.
[23] D. Burton,et al. Macaques vaccinated with live-attenuated SIV control replication of heterologous virus , 2008, The Journal of experimental medicine.
[24] David Heckerman,et al. Marked Epitope- and Allele-Specific Differences in Rates of Mutation in Human Immunodeficiency Type 1 (HIV-1) Gag, Pol, and Nef Cytotoxic T-Lymphocyte Epitopes in Acute/Early HIV-1 Infection , 2008, Journal of Virology.
[25] V. Appay,et al. CD8+ T cell efficacy in vaccination and disease , 2008, Nature Medicine.
[26] Todd M. Allen,et al. Antigen Load and Viral Sequence Diversification Determine the Functional Profile of HIV-1–Specific CD8+ T Cells , 2008, PLoS medicine.
[27] M. A. Farrow,et al. Identification and characterization of HIV-1 CD8+ T cell escape variants with impaired fitness. , 2008, The Journal of infectious diseases.
[28] David A. Price,et al. Superior control of HIV-1 replication by CD8+ T cells is reflected by their avidity, polyfunctionality, and clonal turnover , 2007, The Journal of experimental medicine.
[29] Mario Roederer,et al. Immunization with vaccinia virus induces polyfunctional and phenotypically distinctive CD8+ T cell responses , 2007, The Journal of experimental medicine.
[30] Miles P. Davenport,et al. In Vivo Fitness Costs of Different Gag CD8 T-Cell Escape Mutant Simian-Human Immunodeficiency Viruses for Macaques , 2007, Journal of Virology.
[31] R. Balderas,et al. Corrigendum: Upregulation of PD-1 expression on HIV-specific CD8+ T cells leads to reversible immune dysfunction , 2006, Nature Medicine.
[32] Bin Li,et al. Rapid Reversion of Sequence Polymorphisms Dominates Early Human Immunodeficiency Virus Type 1 Evolution , 2006, Journal of Virology.
[33] R. Koup,et al. PD-1 is a regulator of virus-specific CD8+ T cell survival in HIV infection , 2006, The Journal of experimental medicine.
[34] R. Balderas,et al. Upregulation of PD-1 expression on HIV-specific CD8+ T cells leads to reversible immune dysfunction , 2006, Nature Medicine.
[35] Mario Roederer,et al. HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells. , 2006, Blood.
[36] B. Walker,et al. Fitness Cost of Escape Mutations in p24 Gag in Association with Control of Human Immunodeficiency Virus Type 1 , 2006, Journal of Virology.
[37] Daniel C. Douek,et al. The Rational Design of an AIDS Vaccine , 2006, Cell.
[38] Rob J. De Boer,et al. Estimating Costs and Benefits of CTL Escape Mutations in SIV/HIV Infection , 2006, PLoS Comput. Biol..
[39] Sang Joon Kim,et al. A Mathematical Theory of Communication , 2006 .
[40] G. Pantaleo,et al. HIV-1-specific IFN-gamma/IL-2-secreting CD8 T cells support CD4-independent proliferation of HIV-1-specific CD8 T cells. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[41] M. Mulligan,et al. CD8 T-cell responses in early HIV-1 infection are skewed towards high entropy peptides , 2005, AIDS.
[42] M. Nowak,et al. Determinants of Human Immunodeficiency Virus Type 1 Escape from the Primary CD8+ Cytotoxic T Lymphocyte Response , 2004, The Journal of experimental medicine.
[43] B. Walker,et al. Immune Escape Precedes Breakthrough Human Immunodeficiency Virus Type 1 Viremia and Broadening of the Cytotoxic T-Lymphocyte Response in an HLA-B27-Positive Long-Term-Nonprogressing Child , 2004, Journal of Virology.
[44] Philip J. R. Goulder,et al. HIV and SIV CTL escape: implications for vaccine design , 2004, Nature Reviews Immunology.
[45] Michael P Busch,et al. Dynamics of HIV viremia and antibody seroconversion in plasma donors: implications for diagnosis and staging of primary HIV infection , 2003, AIDS.
[46] Austin L. Hughes,et al. Acute phase cytotoxic T lymphocyte escape is a hallmark of simian immunodeficiency virus infection , 2002, Nature Medicine.
[47] Steven M. Wolinsky,et al. Eventual AIDS vaccine failure in a rhesus monkey by viral escape from cytotoxic T lymphocytes , 2002, Nature.
[48] John F. B. Mitchell,et al. Quantifying the uncertainty in forecasts of anthropogenic climate change , 2000, Nature.
[49] Alessandro Sette,et al. Tat-specific cytotoxic T lymphocytes select for SIV escape variants during resolution of primary viraemia , 2000, Nature.
[50] H. Rammensee,et al. Protective Immunity Does Not Correlate with the Hierarchy of Virus-specific Cytotoxic T Cell Responses to Naturally Processed Peptides , 1998, The Journal of experimental medicine.
[51] P. Klenerman,et al. Positive selection of HIV-1 cytotoxic T lymphocyte escape variants during primary infection. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[52] Xiping Wei,et al. Antiviral pressure exerted by HIV-l-specific cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus , 1997, Nature Medicine.
[53] Martin A. Nowak,et al. Late escape from an immunodominant cytotoxic T-lymphocyte response associated with progression to AIDS , 1997, Nature Medicine.
[54] S. Arya,et al. Identification of RANTES, MIP-1α, and MIP-1β as the Major HIV-Suppressive Factors Produced by CD8+ T Cells , 1995, Science.
[55] B. Korber,et al. Genetic differences between blood- and brain-derived viral sequences from human immunodeficiency virus type 1-infected patients: evidence of conserved elements in the V3 region of the envelope protein of brain-derived sequences , 1994, Journal of virology.
[56] G. Shaw,et al. Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection , 1994, Journal of virology.
[57] D. Ho,et al. Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome , 1994, Journal of virology.
[58] D. Ho,et al. Characterization of human immunodeficiency virus type 1-specific cytotoxic T lymphocyte clones isolated during acute seroconversion: recognition of autologous virus sequences within a conserved immunodominant epitope , 1994, The Journal of experimental medicine.
[59] Charles R. M. Bangham,et al. Human immunodeficiency virus genetic variation that can escape cytotoxic T cell recognition , 1991, Nature.